Quick Answer
SpyGlass Pharma, Inc. reported Stockholders Equity of -$98.84 million for fiscal year 2025.
SpyGlass Pharma, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$98.84M | -63.4% |
| 2024 | -$60.47M | -83.3% |
| 2023 | -$32.98M | — |
- SpyGlass Pharma, Inc. showed a decrease of -63.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2023–2025 period, SpyGlass Pharma, Inc.’s stockholders equity has declined by 199.6% (from -$32.98 million to -$98.84 million).
- The most recent figure is from SpyGlass Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: